Nothing Special   »   [go: up one dir, main page]

Barrow et al., 2019 - Google Patents

The natural cytotoxicity receptors in health and disease

Barrow et al., 2019

View HTML
Document ID
14419393444571425007
Author
Barrow A
Martin C
Colonna M
Publication year
Publication venue
Frontiers in immunology

External Links

Snippet

The Natural Cytotoxicity Receptors (NCRs), NKp46, NKp44, and NKp30, were some of the first human activating Natural Killer (NK) cell receptors involved in the non-MHC-restricted recognition of tumor cells to be cloned over 20 years ago. Since this time many host-and …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features

Similar Documents

Publication Publication Date Title
Barrow et al. The natural cytotoxicity receptors in health and disease
JP7108551B2 (en) Methods and compositions for transducing lymphocytes and their controlled increase
US11738048B2 (en) Immune cell compositions and methods of use for treating viral and other infections
EP3227436B1 (en) Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
US11325948B2 (en) Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
AU2019347873B2 (en) Immunoresponsive cells expressing dominant negative Fas and uses thereof
AU2015357526A1 (en) Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof
AU2015357518A1 (en) Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof
US20220340927A1 (en) Methods and compositions for the modification and delivery of lymphocytes
WO2021178701A1 (en) Methods and compositions for the delivery of modified lymphocyte aggregates
US20200255864A1 (en) Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
TW202146431A (en) Chimeric receptors for use in engineered cells
WO2020047527A2 (en) Methods and compositions for genetically modifying lymphocytes in blood or in enriched pbmcs
US20210317408A1 (en) Methods and compositions for genetically modifying lymphocytes in blood or in enriched pbmcs
KR20230010228A (en) Chimeric antigen receptor (CARS) targeting natural killer cells
KR20240111754A (en) Chimeric adapter polypeptide
CN116033919A (en) System for inducible expression of adapters in immune cells
US20230348560A1 (en) Chimeric ilt receptor compositions and methods
Schlenker Chimeric co-stimulatory receptors as a strategy to improve the performance of T cells in the tumor environment
Sheng Modifications Of Nk-92mi Cell Line Through Third Generation Lentiviral Vector
WO2025029597A1 (en) Chimeric ilt receptor compositions and methods
JP2025500618A (en) Anti-CD84 Antibodies and Chimeric Antigen Receptors
CN118176212A (en) Compositions of Chimeric Antigen Receptor (CAR) signaling molecules and uses thereof